Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Related Articles by Review for PubMed (Select 22054309)

1.

Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes.

Guan J, Wen B, Deng Y, Zhang K, Chen H, Wu X, Ruan L, Tan W.

Virol J. 2011 Nov 4;8:506. doi: 10.1186/1743-422X-8-506.

2.

An overview of hepatitis C vaccines.

Garcia A, Fernandez S, Toro F, De Sanctis JB.

Recent Pat Inflamm Allergy Drug Discov. 2014;8(2):85-91. Review.

PMID:
25000932
3.

Vaccination for hepatitis C virus: closing in on an evasive target.

Halliday J, Klenerman P, Barnes E.

Expert Rev Vaccines. 2011 May;10(5):659-72. doi: 10.1586/erv.11.55. Review.

4.

Virus-like particle-based vaccines against hepatitis C virus infection.

Bellier B, Klatzmann D.

Expert Rev Vaccines. 2013 Feb;12(2):143-54. doi: 10.1586/erv.13.10. Review.

PMID:
23414406
5.

Prospects for prophylactic hepatitis C vaccines based on virus-like particles.

Beaumont E, Roingeard P.

Hum Vaccin Immunother. 2013 May;9(5):1112-8. doi: 10.4161/hv.23900. Epub 2013 Feb 13. Review.

6.

Hepatitis C virus vaccines among people who inject drugs.

Cox AL, Thomas DL.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S46-50. doi: 10.1093/cid/cit329. Review.

7.

Hepatitis C virus vaccines--progress and perspectives.

Fauvelle C, Lepiller Q, Felmlee DJ, Fofana I, Habersetzer F, Stoll-Keller F, Baumert TF, Fafi-Kremer S.

Microb Pathog. 2013 May;58:66-72. doi: 10.1016/j.micpath.2013.02.005. Epub 2013 Mar 7. Review.

PMID:
23499591
8.

Immune responses to HCV and other hepatitis viruses.

Park SH, Rehermann B.

Immunity. 2014 Jan 16;40(1):13-24. doi: 10.1016/j.immuni.2013.12.010. Review.

9.

[Development of an adenovirus vector containing a hepatitis C virus expression cassette and its application].

Yoshida T, Kondoh M, Mizuguchi H, Yagi K.

Yakugaku Zasshi. 2013;133(3):305-11. Review. Japanese.

10.

Pre-existing immunity against vaccine vectors--friend or foe?

Saxena M, Van TT, Baird FJ, Coloe PJ, Smooker PM.

Microbiology. 2013 Jan;159(Pt 1):1-11. doi: 10.1099/mic.0.049601-0. Epub 2012 Nov 22. Review.

11.

Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Patterson LJ, Robert-Guroff M.

Expert Opin Biol Ther. 2008 Sep;8(9):1347-63. doi: 10.1517/14712598.8.9.1347 . Review.

12.

Current progress in development of hepatitis C virus vaccines.

Liang TJ.

Nat Med. 2013 Jul;19(7):869-78. doi: 10.1038/nm.3183. Review.

PMID:
23836237
13.

Ever closer to a prophylactic vaccine for HCV.

Swadling L, Klenerman P, Barnes E.

Expert Opin Biol Ther. 2013 Aug;13(8):1109-24. doi: 10.1517/14712598.2013.791277. Epub 2013 May 7. Review.

14.

Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.

Capone S, D'Alise AM, Ammendola V, Colloca S, Cortese R, Nicosia A, Folgori A.

Expert Rev Vaccines. 2013 Apr;12(4):379-93. doi: 10.1586/erv.13.15. Review.

PMID:
23560919
15.

Challenges in manufacturing adenoviral vectors for global vaccine product deployment.

Vellinga J, Smith JP, Lipiec A, Majhen D, Lemckert A, van Ooij M, Ives P, Yallop C, Custers J, Havenga M.

Hum Gene Ther. 2014 Apr;25(4):318-27. doi: 10.1089/hum.2014.007. Epub 2014 Apr 2. Review.

PMID:
24593243
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk